Contract Manufacturing Agreements: Key Terms Every Brand Owner Should Understand Before Signing

For most new health, beauty and supplement brands, the contract manufacturing agreement is the single most important document they will ever sign — and the one they read least carefully. It decides who owns the formula, what happens to the price after launch, whether a brand can move factories, and who is legally responsible if a product fails a test. This guide explains, in plain English, the terms that matter most before a brand owner signs.

Quick answer: what is a contract manufacturing agreement, and what should you check?

A contract manufacturing agreement is the legal contract between a brand owner and the factory (an OEM or ODM manufacturer) that produces its products. Before signing, a brand owner should confirm seven things in writing: who owns the formula and trademark, whether pricing can change and how, minimum order commitments, confidentiality, quality and liability, regulatory responsibility, and how the relationship can end. The biggest risk is not price — it is signing away formula ownership or agreeing to open-ended terms that make it costly to leave. A qualified lawyer should review any agreement before signature.

Key takeaways

• The formula-ownership clause matters more than the unit price. A custom formula developed and paid for by the brand should be owned by the brand, in writing.
• Verbal quotes are not commitments. Price, minimum order quantity (MOQ) and lead time only bind the factory when they are written into the agreement.
• Regulatory responsibility must be assigned. Product notification, labelling accuracy and record-keeping should be clearly allocated, not assumed.
• Exit terms decide leverage. Termination notice, ownership of leftover materials, and hand-over of documents determine how freely a brand can switch factories.
• An agreement is not legal advice. Templates and checklists help a brand ask the right questions; a qualified lawyer should still review the final contract.

Who this is for

This article is written for founders and brand owners — particularly in cosmetics, skincare, supplements and wellness — who are about to appoint an OEM or ODM manufacturer and want to understand the contract before signing it. It assumes no legal background. It is educational, not a substitute for advice from a qualified lawyer familiar with the brand’s market and product category.

What is a contract manufacturing agreement?

A contract manufacturing agreement is the written contract that governs how a factory makes products for a brand it does not own. In this arrangement, an OEM (Original Equipment Manufacturer) produces to the brand’s specification, while an ODM (Original Design Manufacturer) supplies its own ready-made formulations that the brand labels as its own. The agreement sets out what will be made, at what price and quantity, to what quality standard, who owns the intellectual property, and what each side must do if something goes wrong.

Analytically, the agreement does two jobs at once. It is a supply contract — covering price, volume and delivery — and it is an ownership and risk contract — covering formulas, trademarks, confidentiality and liability. Many disputes happen because brand owners focus on the first job (the quotation) and overlook the second. The choice of manufacturing path itself shapes several of these terms, a topic explored in Private Label vs Custom Formulation.

Which contract terms matter most before signing?

The terms that most often cause disputes are formula ownership, pricing, order commitments and exit rights — not the day-one unit cost. The table below summarises the clauses a brand owner should read line by line, what to look for, and why each one matters.

Clause	What to check	Why it matters
IP & formula ownership	Who owns a custom formula the brand paid to develop; who owns the brand name and artwork.	Decides whether the brand can ever move the product to another factory.
Pricing & adjustments	Fixed-price period, notice for increases, and how raw-material cost changes are handled.	Protects margins after launch, when switching is hardest.
MOQ & supply commitment	Minimum order quantity, re-order minimums, and any obligation to buy a set volume.	Determines cash tied up in stock and exposure if sales are slow.
Confidentiality (NDA)	Whether the brand’s formula, supplier list and plans are protected, and for how long.	Stops a differentiated product being replicated for a competitor.
Quality & specification	Agreed specification sheet, testing, rejection rights and handling of defective batches.	Defines what “acceptable” means before a dispute, not after.
Liability & indemnity	Who is responsible for a manufacturing fault versus a labelling or marketing fault.	Allocates the cost of recalls, complaints and regulatory action.
Regulatory responsibility	Who handles product notification, registration and required records.	Prevents a compliance gap that neither side thought it owned.
Term & termination	Contract length, notice period, and what happens to stock, moulds and documents on exit.	Decides how easily — and at what cost — a brand can leave.

Who owns the formula — the brand or the manufacturer?

Ownership depends on how the formula was created, and it should be stated explicitly in the agreement rather than left to assumption. When a factory supplies an existing ODM (stock) formula, the manufacturer normally retains ownership and may sell similar versions to other brands — the brand owns its name and packaging, not the recipe. When a brand commissions and pays for a genuinely custom formula, it is reasonable for the brand to own that formulation, but this only holds if the contract says so in writing.

The practical risk is a middle ground that many founders miss: a formula described as “customised” that is really a lightly adjusted house base the factory still controls. In that case, moving to a new manufacturer can mean rebuilding and re-testing the product from scratch. As analysis, not legal advice, brand owners are wise to clarify three points — who owns the formula, whether the factory may reuse it for others, and whether the brand can take the specification elsewhere. Registering the brand name as a trademark, separately from any formula question, is handled through a national IP office such as the Intellectual Property Corporation of Malaysia (MyIPO).

Written terms, not verbal assurances, are what bind a manufacturer. Photo: Pexels.

How should pricing and minimum orders be written into the agreement?

Pricing and order commitments should be fixed to a defined period and mechanism, not left to a single verbal quote. A quotation given during courtship is an invitation, not a promise; it becomes binding only when the agreement specifies the unit price, the period it is held for, the notice required before any increase, and how raw-material fluctuations are shared. Without this, a brand can find its costing model — the subject of Costing a Beauty or Supplement Product — undone months after launch.

Minimum order quantity works the same way. The agreement should state the first-order MOQ, the re-order minimum (which is sometimes lower), and whether the brand is committing to a total volume over time. Founders sometimes accept a high MOQ to secure a better unit price, then carry unsold stock — a trade-off examined in Understanding MOQ. Under Malaysian law, the general framework for what makes such promises enforceable is set out in the Contracts Act 1950, which is why written, signed terms carry the weight that conversations do not.

Who is responsible for regulatory compliance?

Regulatory responsibility must be assigned in the contract, because a gap here can stop a product from being sold legally. In many markets the brand owner is the party accountable for a product being properly notified or registered before sale, even when the factory prepares the technical file. For cosmetics in Malaysia, for example, product notification runs through the National Pharmaceutical Regulatory Agency (NPRA), and the brand should confirm in writing whether the manufacturer submits the notification or merely supplies the supporting information.

The safest approach is to name, clause by clause, who does what: who holds the notification, who guarantees that the label matches the approved formula, who keeps batch and stability records, and who acts if the authority raises a query. This complements the product-side view in Cosmetic Compliance 101. Leaving compliance implied is how brands discover, after an audit, that a step nobody owned was never done.

What red flags should brand owners watch for?

The clearest warning signs appear before signing, in how a manufacturer handles the paperwork itself. Based on common patterns rather than any single case, the following deserve caution:

• Reluctance to put quotes in writing. A factory unwilling to commit price or MOQ to the contract may not intend to hold them.
• Silence on formula ownership. If a “custom” project has no ownership clause, ownership is effectively the factory’s by default.
• No specification sheet. Without an agreed spec, there is no objective standard to reject a bad batch against.
• Open-ended exclusivity on the brand’s side only. A clause that binds the brand to one factory, while the factory is free to serve competitors, is asymmetric.
• Vague termination terms. If it is unclear how to leave, or who keeps tooling and documents, the cost of leaving is unknown.

Negotiating clarity before signing is easier than resolving ambiguity afterwards. Photo: Pexels.

What questions should a brand owner ask before signing?

A short set of direct questions surfaces most of the risk in a manufacturing agreement. Before signing, a brand owner can ask the manufacturer to answer, in writing:

• Who owns the formula if we pay to develop it, and may you sell it to others?
• How long is this price held, and what notice applies before any increase?
• What is the first-order MOQ, and what is the re-order minimum?
• Who submits the product notification or registration — you or us?
• What is the agreed specification, and how are out-of-spec batches handled?
• What notice is needed to end the agreement, and what do we take with us?

These questions overlap with supplier selection more broadly, covered in How to Choose the Right OEM/ODM Manufacturer. A manufacturer that answers them clearly and commits the answers to the contract is demonstrating exactly the transparency a long partnership needs.

Frequently asked questions

Do I need a lawyer to review a contract manufacturing agreement?

For any agreement involving custom formulas, exclusivity or significant order commitments, a review by a qualified lawyer is strongly advisable. A checklist helps a brand owner understand the terms and ask better questions, but it does not replace advice from someone who knows the brand’s market, product category and applicable law. The cost of a review is usually small next to the cost of an ownership or liability clause going wrong.

Can I move to another manufacturer later?

It depends almost entirely on what the agreement says about formula ownership and termination. If the brand owns its formula and the contract allows a clean exit, switching is feasible, though it still involves re-validation and possibly re-notification. If the factory owns the formula, moving may mean reformulating from scratch. This is why ownership and exit terms deserve attention before signing, not after a dispute begins.

Is an ODM (stock) formula worse than a custom one?

Neither is inherently better; they carry different ownership implications. An ODM formula is faster and cheaper but is usually owned by the factory and may appear in competitors’ products. A custom formula can be owned by the brand and differentiated, but costs more and takes longer to develop. The right choice depends on budget, timeline and how much differentiation the brand needs — a decision framed in more detail in the private-label-versus-custom comparison linked above.

What happens to my stock and materials if the contract ends?

That should be defined in the termination clause rather than negotiated in the moment. A clear agreement states who owns any remaining finished goods, packaging, raw materials and tooling, and on what terms the brand can collect or buy them. Silence here often leaves stock and materials in limbo precisely when the relationship is already strained.

Should confidentiality be a separate NDA or part of the main agreement?

Either can work, provided the protection is real and mutual where appropriate. What matters is that the brand’s formula, plans and supplier information are covered, that the obligation survives after the contract ends, and that it is signed before sensitive details are shared. A confidentiality clause inside the main agreement is common; a standalone NDA signed earlier, during initial discussions, is also sensible.

---

Sources & further reading

• Contracts Act 1950 (Laws of Malaysia) — general framework for enforceable agreements.
• Intellectual Property Corporation of Malaysia (MyIPO) — trademark and IP registration.
• National Pharmaceutical Regulatory Agency (NPRA) — cosmetic and product notification in Malaysia.
• World Intellectual Property Organization (WIPO) — background on trademarks and IP in supply relationships.

Limitations & disclosure

This article is general educational analysis, not legal advice, and it does not create any adviser relationship. Contract law, ownership rules and regulatory responsibilities vary by country, product category and the specific wording of each agreement; brand owners should consult a qualified lawyer and the relevant regulator for their situation. Where regulatory examples are given, they reflect the Malaysian context at the time of writing and may change.

---

Disclosure: Creaton Poh is the pen name of Poh Tze Kheng, founder of the ORIZI Group, a Malaysian OEM/ODM manufacturer. This article is educational and independent, and is not promotional.

Written by Creaton Poh
Industry Researcher • Author • Vlogger • Manufacturing Strategist
Turning ideas into products. Turning experience into knowledge.

Connect with Poh Tze Kheng on LinkedIn.